TY - JOUR
T1 - Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
AU - Vila, Jordi
AU - Ruiz, Joaquim
AU - Goñi, Pilar
AU - De Anta, Teresa Jimenez
PY - 1997
Y1 - 1997
N2 - Mutations in the parC gene, which encodes a subunit of topoisomerase IV, were determined in 21 epidemiologically unrelated clinical isolates of Acinetobacter baumannii. Our studies highlight the conserved sequences in the quinolone-resistance-determining region of the parC gene from A. baumannii and other bacteria. Nine of ten isolates with MICs of ciprofloxacin of ≤ 32 mg/L showed a change of Ser80 to Leu and one showed a change of Glu84 to Lys. These results suggest that ParC from A. baumannii is a secondary target for quinolones and that mutations at residues Ser80 and Glu84, when combined with mutations at Ser83 of GyrA, may render A. baumannii highly resistant to quinolones.
AB - Mutations in the parC gene, which encodes a subunit of topoisomerase IV, were determined in 21 epidemiologically unrelated clinical isolates of Acinetobacter baumannii. Our studies highlight the conserved sequences in the quinolone-resistance-determining region of the parC gene from A. baumannii and other bacteria. Nine of ten isolates with MICs of ciprofloxacin of ≤ 32 mg/L showed a change of Ser80 to Leu and one showed a change of Glu84 to Lys. These results suggest that ParC from A. baumannii is a secondary target for quinolones and that mutations at residues Ser80 and Glu84, when combined with mutations at Ser83 of GyrA, may render A. baumannii highly resistant to quinolones.
UR - http://www.scopus.com/inward/record.url?scp=0030851997&partnerID=8YFLogxK
U2 - 10.1093/jac/39.6.757
DO - 10.1093/jac/39.6.757
M3 - Artículo
C2 - 9222045
AN - SCOPUS:0030851997
SN - 0305-7453
VL - 39
SP - 757
EP - 762
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
IS - 6
ER -